View Article

Abstract

In 2023, Pakistan faced a widespread outbreak of conjunctivitis, affecting nearly 400,000 individuals. The rapid transmission was driven by environmental factors, infectious agents, and allergens, with common symptoms including eye redness, swelling, tearing, and discharge. In response, a pioneering bioinformatics study examined the TLR4 gene variants, given TLR4 role in immune response, although direct genetic links to conjunctivitis are not yet established. Using Swiss Model and SAVESV6.1, a 3D model of TLR4 was developed, verified with a QMEAN-Z score of -0.81 and a ProSA score of -7.51, affirming its reliability. This study identified 82 highly deleterious nsSNPs through multiple computational tools, with 12 significantly harmful variants N44H, S207C, N185S, and D84A exhibiting notable structural impacts. Docking studies with both wild-type and mutant forms of TLR4 tested 17 compounds, revealing Apigenin, GN8, SYUIQ-5, S-adenosylmethionine, Vixotrigine, and Tetracycline as potential inhibitors due to their strong affinities for TLR4. These findings suggest that these compounds may offer therapeutic potential for conjunctivitis, though further experimental validation is needed.

Keywords

TLR4, SIFT, Poly Phen, nsSNPs, HOPE

Introduction

Conjunctivitis is an inflammatory condition impacting the conjunctiva, the transparent membrane that covers the white of the eye and the inner eyelids. This condition is marked by symptoms such as excessive discharge, sensitivity to light, redness of the conjunctiva, and itching. Conjunctivitis can be triggered by multiple factors, including allergens, viral agents, and bacterial infections [1]. A recent ophthalmology study in the USA highlights that eye diseases treated in emergency departments incur an annual cost of $2 billion. Conjunctivitis alone contributes around 28% of this total, underscoring the substantial financial strain eye conditions place on healthcare resources [2].  Conjunctivitis can be caused by several viral pathogens, including the varicella-zoster virus (VZV), herpes simplex virus (HSV) and adenovirus [3]. Fungi are significant contributors to eye infections, especially in tropical and developing regions. They can cause severe ocular candidiasis and keratitis, which may result in permanent vision loss [4].Various bacteria, including Gram-positive types (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Bacillus species), as well as Gram-negative (Pseudomonas aeruginosa, Moraxella, and Haemophilus spp.,) often cause conjunctivitis and keratitis. They may enter the eye through skin contact, the respiratory tract, or external infection from another person[4, 5]. Genetic variants influencing angiogenic responsiveness, such as the pink-eyed mutation in the oca2 gene, impact pink eye development in mice by altering angiogenesis. This mutation modifies blood vessel formation within the eye, contributing to changes associated with pink eye [6]. Allergic conjunctivitis is widespread, affecting between 15% and 40% of various populations. A study in Saudi Arabia found an age- and sex-adjusted prevalence of 70.5% among adults in the western region [7]. Pakistan reported 400,000 cases of viral conjunctivitis, with a particularly high surge in cases observed in Karachi [8]. Moreover, variants in the interleukin-4 gene (rs2243250) and its receptor (rs1805010) have been associated with viral conjunctivitis. Research has revealed significant differences in genotype distributions between viral conjunctivitis patients and healthy controls, suggesting these genetic variants may influence susceptibility to viral infections leading to conjunctivitis [9].

The genes associated with Herpes Simplex Virus Type 1 ocular infection include UL24, UL29 (ICP8), UL41 (VHS), UL53 (gK), UL54 (ICP27), UL56, ICP4, US1 (ICP22), US3, and gG, play critical roles in the virus’s replication, immune evasion, and ocular tissue damage during infection [3]. Toll-like receptor 4 (TLR4) is significant in the innate immune response by recognizing pathogen-associated molecular patterns (PAMPs) and initiating inflammatory signaling pathways. In allergic conjunctivitis, TLR4 can be activated by environmental allergens, such as pollen, dust mites, or pollutants, which are perceived as threats by the immune system [10]. The TLR4 (ARMD10 or CD284) gene is located on chromosome 9q32 in humans and is composed of several exons and introns, which are transcribed into mRNA and subsequently translated into the TLR4 protein. It spans multiple kilobases and is classified as a type I transmembrane protein, characterized by a single transmembrane domain that anchors it within the cell membrane. The extracellular domain of TLR4 plays a key role in recognizing PAMPs, such as lipopolysaccharides (LPS), while the intracellular domain is involved in triggering signaling pathways [11]. The extracellular region of TLR4 includes a leucine-rich repeat (LRR) motif, essential for binding ligands. This allows TLR4 to identify specific molecular signatures from pathogens, including bacterial LPS, which activates an immune response. The intracellular portion contains the TIR domain, which is responsible for initiating downstream signaling after activation. The TIR domain interacts with adaptor proteins, including MyD88 and TRIF, leading to the activation of inflammatory pathways such as NF-?B and MAPK, which ultimately results in the release of pro-inflammatory cytokines [12, 13]. Upon ligand binding, TLR4 typically dimerizes, often in conjunction with the co-receptor MD-2, which is necessary for LPS and other PAMP recognition. The TLR4 gene also undergoes alternative splicing, producing various isoforms that may have different functional characteristics or tissue-specific expression. Genetic variations in the TLR4 gene can alter its function and are linked to a range of conditions, including sepsis, autoimmune diseases, and allergic reactions [14].

Furthermore, TLR4 expression was detected in circulating CD4+ T cells from individuals with chronic allergic conjunctivitis, and in conjunctival epithelial cells. The D299G (rs4986790) and T399I have been studied and 18% TLR4 mutations, with a significantly higher incidence of gram-negative infections that may contribute to an increased susceptibility to allergic conjunctivitis [15, 16]. When peripheral blood mononuclear cells (PBMCs) from patients were stimulated with allergens such as Der p, a significant increase in both TLR4 expression and activation markers (CD69) was observed in CD4+ T cells. This suggests that allergen-specific stimulation can enhance the TLR4 activity, which may contribute to the Th2 inflammatory microenvironment commonly seen in allergic responses [15]. Bioinformatics tools play a crucial role in understanding the genetic foundations of infectious diseases, which is essential for early detection of eye infections and effective epidemiological responses. By utilizing a range of prediction tools, we categorized the nsSNPs in the TLR4 gene and identified those most likely to disrupt receptor function, potentially leading to diseases such as conjunctivitis. Future research will focus on exploring the in-silico structural and functional effects of missense mutations in human TLR4, specifically with pink eye infections. This approach will aim to identify potential treatment targets and enhance drug precision. Such strategies hold promises for improving treatment efficacy and developing preventative measures to reduce infection rates.

  1. MATERIALS AND METHODS

2.1 Screening datasets

The National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov) has made available the hTLR4 gene data, including unique SNP findings, through their dbSNP database (http://www.ncbi.nlm.nih.gov/snp). Additionally, UniProt (https://www.uniprot.org) is used to obtain protein sequence information, allowing for detailed insights into its structure and function. The Overall methodology of the present study is given in Figure 1.

       
            Workflow of the current study.png
       

Figure 1. Workflow of the current study

2.2 Prediction of nsSNPs

SNPNexus tool (https://www.snp-nexus.org/v4) simplifies the selection and prioritization of known and novel genomic variants [17]. Sorting Intolerant From Tolerant (SIFT) uses sequence homology to identify deleterious SNPs, analyzing amino acid variations that affect protein phenotypic and functional alterations [18]. PolyPhen analyzes protein composition and functionality by analyzing amino acid substitutions using protein sequence, and substitution information. The score ranges from 0.0 to 1.0 indicating deleterious or tolerated variants [19]. Protein Analysis through Evolutionary Relationship (PANTHER) (https://www.pantherdb.org/tools) uses evolutionary relationships and the Hidden Markov Model (HMM) for analysis [20]. The TLR4 sequence, mutant, and position are submitted to the query [21]. Amino acid substitutions on functional proteins are categorized as benign or harmful by the web server MutPred2 (http://mutpred2.mutdb.org), with "pathogenic mutation" values ranging from 0.5 to 1.0 [22]. Polyphen-2-Polymorphism Phenotyping v2 (http://genetics.bwh.harvard.edu/pph2/) predicts the consequence of an amino acid substitution on a protein's structure and, hence, function [23]. The PredictSNP (https://loschmidt.chemi.muni.cz/predictsnp1) uses input data from various tools to predict the impact of changing one amino acid, offering increased effectiveness and accuracy [24].

2.3 Impact of disease-associated nsSNPs on protein stability.

SuSpect (http://www.sbg.bio.ic.ac.uk/suspect) analyzes disease prediction using sequence-based and annotation methods, reducing annotation bias and ranking genes based on multiple evidence lines [25]. SNPs & GO (https://snps.biofold.org/snps-and-go/snps-and-go.html) uses functional annotation of protein sequences to determine variation associated with a disease [22]. Meta SNP (https://snps.biofold.org/meta-snp) is used to predict a single nucleotide variation in protein sequence. The output value>0.5 is considered as a disease, and <0>[26].  iStable (http://predictor.nchu.edu.tw/iStable) is a server that predicts protein stability changes using sequence or structure information, combining five forecasting instruments and a variety of feature coding and prediction techniques [27].

2.4 Homology Modeling Prediction

The SWISS-MODEL algorithm (https://swissmodel.expasy.org) is used for protein structural homology modeling that constructs accurate protein structures by utilizing closely related templates. The process begins by clustering known protein structures and selecting the template with the highest sequence identity to the target protein [28]. Following model construction, SWISS-MODEL evaluates the model's quality using several validation metrics, including the Ramachandran plot, QMEAN score, and MolProbity score. These assessments provide insights into the geometric quality and reliability of the predicted structure [29].

2.5 Structural Verification Analysis

SAVESv6.1 (https://saves.mbi.ucla.edu) was used to select and validate a structural model, incorporating PROCHECK and ERRAT for overall quality. A RAMACHANDRAN plot assessed model quality, determining the amino acid preferred area and dihedral angle. This plot of the torsional angles phi (?) and psi (?) of the residues (amino acids) contained in a peptide. By Ramachandran plot helps to determine which torsional angles are permitted and can obtain insight into the structure of peptides. The model with satisfying stereo-chemical quality was further assessed by QMEAN and ProSA was used to compute Z score values for the models [30].

2.6 Structural Superimposition

Template Modeling alignment (TM-Align) tool (https://zhanggroup.org/TM-align) used for comparing the structural similarities between wild-type and mutant protein models. It calculates the TM-score and Root Mean Square Deviation (RMSD) to assess the degree of structural divergence quantitatively [31]. In contrast, RMSD quantifies the average distance between corresponding atoms in the aligned proteins; higher RMSD values signify greater structural divergence [32].

2.7 Structural analysis of variants

Mutation 3D (http://www.mutation3d.org/about.shtml) is a valuable computational tool designed to analyze the effects of amino acid substitutions on protein models and structures. This platform facilitates the identification of mutation clusters and functional hotspots, contributing to a deeper understanding of the implications of these alterations on protein function. The HOPE (Have (y) Our Protein Explained) program (https://www3.cmbi.umcn.nl/hope/input) collects details from multiple sources to offer insights into the effects of variants on TLR4 structure. After the FASTA format is submitted, it finds the mutant residue and goes on to the following step of analysis [33].

 2.8 Ligand Preparation

PubChem (https://pubchem.ncbi.nlm.nih.gov) is a comprehensive database that houses a wide range of chemical compounds, primarily small molecules, but also includes larger compounds such as lipids, peptides, carbohydrates, nucleotides, and chemically modified macromolecules. It provides detailed information on chemical structures, identifiers, chemical and physical properties, biological activities, patents, and health, safety, and toxicological data [34].

2.9 Molecular screening analysis

PyRx (https://pyrx.sourceforge.io) is a virtual screening tool used in computational drug discovery to evaluate libraries of compounds for potential therapeutic targets. It allows users to perform Virtual Screening on various platforms, guiding them through each step of the process from data preparation to job submission and result analysis. Discovery Studio Visualizer (https://discover.3ds.com/discovery-studio-visualizer-download) was then employed to examine the ligand-protein interactions, and both the ligand and protein structures were represented in 2D and 3D formats as PNG files for visualization. This workflow enables efficient drug discovery by predicting molecular interactions and identifying potential drug candidates [35].

RESULTS

    1. Dataset download

In this study, a total of 8,702 SNPs of the human TLR4 gene were downloaded from the dbNCBI database. These SNPs include 4,275 in UTR regions, with 3,824 located in the 3' UTR region and 451 in the 5' UTR region. There are also 15,843 SNPs in intronic regions, 799 synonymous variants, and 1,928 non-synonymous SNPs. Additionally, the dataset comprises 2,601 SNPs in the 3' downstream region, 2,902 SNPs in the 5' upstream region, 157 exonic mutations, and 208 SNPs in non-coding regions, as illustrated in Figure 2. For further analysis, the protein sequence of O00206 was retrieved from the UniProt database. The human TLR4 gene is located in the 9q33.1 region of chromosome 9. It has a molecular weight of 95 kDa and consists of 4 exons and 10 distinct introns.

       
            Bar Plot presents the SNPs in different regions of the TLR4 Gene.png
       

Figure 2. Bar Plot presents the SNPs in different regions of the TLR4 Gene.

3.2 Functional Prediction of nsSNPs

A total of 8,702 rsIDs were submitted to SNPnexus, resulting in predictions for 1,724 variants, with 878 classified as deleterious and 972 as tolerated based on the SIFT algorithm (Figure 3a). Additionally, PolyPhen analysis revealed that 469 nsSNPs were likely to be damaging, 355 were categorized as possibly damaging, and 1,026 were identified as benign (Figure 3b). Among these, 132 SNPs were found to be common and were all predicted to be probably damaging (Table 1). These findings highlight the potential significance of these variants in terms of their impact on protein function and their possible associations with disease.

       
            Detrimental missense nsSNPs are predicted by.png
       

Figure 3. Detrimental missense nsSNPs are predicted by a) SIFT algorithm 0 and b) PolyPhen


Table 1. Prediction of functional consequences of coding variants identified by SNPnexus

Variation ID

Mutation

Polyphen

SIFT

Variation ID

Mutation

Polyphen

SIFT

Score

Prediction

Score

Prediction

Score

Prediction

Score

Prediction

rs1383009042

P145L

0.911

PD

0

D

rs776282454

G699R

0.993

PD

0

D

rs755813457

I320T

0.911

PD

0

D

rs1157906794

G715V

0.993

PD

0

D

rs55786277

R804W

0.913

PD

0

D

rs200905500

R787H

0.993

PD

0

D

rs137853920

C281Y

0.915

PD

0

D

rs377719663

Y709C

0.994

PD

0.01

D

rs200246890

N205H

0.922

PD

0

D

rs892362464

L59M

0.995

PD

0

D

rs199930089

G715R

0.924

PD

0

D

rs201521400

F237L

0.996

PD

0

D

rs1044303225

V32A

0.929

PD

0

D

rs199763503

L658R

0.996

PD

0

D

rs1038463767

V735F

0.93

PD

0

D

rs1194635312

Y674C

0.996

PD

0

D

rs1416546558

N690S

0.932

PD

0.01

D

rs754642038

V736A

0.996

PD

0

D

rs773429738

L335I

0.933

PD

0

D

rs777803994

L802Q

0.996

PD

0

D

rs757953593

I247T

0.935

PD

0

D

rs1363147767

G252S

0.997

PD

0

D

rs1159116911

T151I

0.936

PD

0

D

rs1194292799

S455T

0.997

PD

0

D

rs201114738

S381G

0.939

PD

0

D

rs1194292799

S415T

0.997

PD

0

D

rs1163840909

E31V

0.94

PD

0

D

rs80197996

L470F

0.997

PD

0

D

rs370421152

V134L

0.94

PD

0

D

rs200787883

F492V

0.997

PD

0

D

rs762970720

V736L

0.946

PD

0

D

rs55905951

A676G

0.997

PD

0

D

rs1472004859

L117S

0.947

PD

0

D

rs761598705

H708R

0.997

PD

0

D

rs199666264

R257P

0.949

PD

0

D

rs750790595

R787C

0.997

PD

0.01

D

rs55799839

L260P

0.95

PD

0

D

rs769239861

R87S

0.998

PD

0

D

rs759420110

L571I

0.952

PD

0.01

D

rs56302444

I93V

0.998

PD

0.03

D

rs749872850

E685G

0.952

PD

0.01

D

rs370421152

V134M

0.998

PD

0

D

rs747209292

K694N

0.952

PD

0

D

rs188543451

L138P

0.998

PD

0

D

rs201835255

R257C

0.954

PD

0.01

D

rs993554067

L208F

0.998

PD

0

D

rs766151559

F516I

0.955

PD

0

D

rs2770145

C306W

0.998

PD

0

D

rs368003192

R810L

0.957

PD

0.01

D

rs770682940

N361K

0.998

PD

0.01

D

rs1235644534

N44H

0.961

PD

0

D

rs765968259

N721S

0.998

PD

0.02

D

rs769767782

V132L

0.964

PD

0.01

D

rs1258063271

A754V

0.998

PD

0

D

rs1301599599

V32M

0.965

PD

0.05

D

rs748382304

I769T

0.998

PD

0

D

rs199561420

S441L

0.965

PD

0

D

rs55751501

A814T

0.998

PD

0.01

D

rs56101219

I722V

0.968

PD

0

D

rs1301599599

V32L

0.999

PD

0.05

D

rs61734367

N361D

0.97

PD

0.01

D

rs201613484

L104F

0.999

PD

0

D

rs775401427

P49S

0.972

PD

0

D

rs200168998

I162T

0.999

PD

0

D

rs754342091

Y98C

0.972

PD

0

D

rs77214890

D181Y

0.999

PD

0

D

rs765289408

S105C

0.973

PD

0.03

D

rs759469467

I187S

0.999

PD

0

D

rs972966550

L511W

0.975

PD

0

D

rs1440077974

L233S

0.999

PD

0

D

rs1445128804

G765D

0.975

PD

0.01

D

rs777887873

L401Q

0.999

PD

0

D

rs1480203162

L375F

0.976

PD

0

D

rs777887873

L401P

0.999

PD

0

D

rs1480203162

L335F

0.976

PD

0

D

rs201792813

Y652C

0.999

PD

0

D

rs954875750

F237S

0.977

PD

0

D

rs751229651

V678A

0.999

PD

0

D

rs917000574

G279S

0.978

PD

0.01

D

rs751229651

V638A

0.999

PD

0

D

rs1256844267

T756P

0.979

PD

0

D

rs779420060

W687R

0.999

PD

0

D

rs780472681

S762I

0.979

PD

0.01

D

rs1174477453

V688L

0.999

PD

0

D

rs762746728

L307F

0.98

PD

0.03

D

rs1282672274

G699V

0.999

PD

0

D

rs1353182806

G726S

0.98

PD

0

D

rs56101219

I722F

0.999

PD

0

D

rs56380595

P823T

0.98

PD

0.02

D

rs746352626

G726D

0.999

PD

0

D

rs897794510

S207C

0.981

PD

0

D

rs746352626

G726V

0.999

PD

0

D

rs902036821

D194N

0.982

PD

0.02

D

rs1287623116

S744G

0.999

PD

0

D

rs1314441656

Q430P

0.983

PD

0

D

rs1048072828

T793A

0.999

PD

0

D

rs1216019140

C340W

0.984

PD

0

D

rs779025130

C40Y

1

PD

0

D

rs2770144

V310G

0.985

PD

0

D

rs868027365

D84N

1

PD

0

D

rs202114774

L519V

0.985

PD

0

D

rs760962514

D84A

1

PD

0

D

rs199632399

R745C

0.985

PD

0

D

rs1044303225

C88R

1

PD

0

D

rs766243776

N309Y

0.986

PD

0

D

rs766539584

L152V

1

PD

0

D

rs748810494

V134A

0.987

PD

0

D

rs537921846

N160S

1

PD

0

D

rs202040652

T793I

0.987

PD

0

D

rs1281579352

P168H

1

PD

0

D

rs199930089

G715S

0.988

PD

0

D

rs1296130154

N185S

1

PD

0

D

rs988829747

I742T

0.988

PD

0

D

rs371871286

N213K

1

PD

0

D

rs201897073

I146T

0.989

PD

0

D

rs371871286

N173K

1

PD

0

D

rs919321567

L372Q

0.989

PD

0.01

D

rs202089517

S407T

1

PD

0.04

D

rs1394250328

I742F

0.989

PD

0.01

D

rs934780727

N409S

1

PD

0

D

rs376443096

D428N

0.99

PD

0

D

rs764148809

L452R

1

PD

0

D

rs1382563975

V716M

0.99

PD

0

D

rs201456149

D453G

1

PD

0

D

rs373109368

L182V

0.992

PD

0.01

D

rs1285033378

C585Y

1

PD

0

D

rs1388911129

L779F

0.992

PD

0

D

rs1354283847

C609Y

1

PD

0

D

rs200139449

G803V

0.992

PD

0

D

rs1233324596

C609W

1

PD

0

D

rs1346126850

N481D

0.993

PD

0

D

rs200497661

R731Q

1

PD

0

D


*D=Deleterious; PD= Probably Damaging

3.3 Prediction of functional impact of mutation

The analysis of nsSNPs using PANTHER, Predict SNP, and PolyPhen2 revealed significant insights into their potential impact on protein function (Table 2). PANTHER classified 96 nsSNPs as Possibly Damaging, 28 as Probably Benign, and 8 as Probably Damaging, with specific mutations (R810L, C306W, and L401Q) identified as likely impairing protein function. Predict SNP found 104 SNPs to have a detrimental effect and 28 to be neutral. PolyPhen2 predicted all 128 SNPs to be Probably Damaging, with a few exceptions, such as S415T, I769T, and P168H, which were considered benign, and Y652C, which was marked as possibly damaging. These results suggest that many of the nsSNPs may have a detrimental effect on protein function, warranting further experimental investigation.


Table 2. List of disease linked variants predicted by computational tools.

Variation ID

Mutation

PANTHER

Polyphen2

Predict SNP

   

Score

Prediction

Score

Prediction

Prediction

rs1383009042

P145L

0.5

Possibly Damaging

0.992

Probably Damaging

Neutral

rs755813457

I320T

0.19

Probably Benign

0.965

Probably Damaging

Deleterious

rs55786277

R804W

0.13

Probably Benign

0.999

Probably Damaging

Deleterious

rs137853920

C281Y

0.5

Possibly Damaging

0.998

Probably Damaging

Deleterious

rs200246890

N205H

0.5

Possibly Damaging

0.998

Probably Damaging

Deleterious

rs199930089

G715R

0.5

Possibly Damaging

0.992

Probably Damaging

Deleterious

rs1044303225

V32A

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1038463767

V735F

0.5

Possibly Damaging

0.986

Probably Damaging

Neutral

rs1416546558

N690S

0.27

Probably Benign

0.988

Probably Damaging

Neutral

rs773429738

L335I

0.5

Possibly Damaging

0.992

Probably Damaging

Neutral

rs757953593

I247T

0.5

Possibly Damaging

0.982

Probably Damaging

Neutral

rs1159116911

T151I

0.27

Probably Benign

0.965

Probably Damaging

Deleterious

rs201114738

S381G

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs1163840909

E31V

0.19

Probably Benign

0.801

Probably Damaging

Deleterious

rs370421152

V134L

0.5

Possibly Damaging

0.941

Probably Damaging

Neutral

rs762970720

V736L

0.5

Possibly Damaging

0.972

Probably Damaging

Deleterious

rs1472004859

L117S

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs199666264

R257P

0.27

Probably Benign

1

Probably Damaging

Deleterious

rs55799839

L260P

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1235644534

N44H

0.13

Probably Benign

0.999

Probably Damaging

Deleterious

rs759420110

L571I

0.5

Possibly Damaging

0.992

Probably Damaging

Deleterious

rs749872850

E685G

0.5

Possibly Damaging

0.996

Probably Damaging

Deleterious

rs747209292

K694N

0.5

Possibly Damaging

0.996

Probably Damaging

Deleterious

rs201835255

R257C

0.27

Probably Benign

1

Probably Damaging

Deleterious

rs766151559

F516I

0.85

Possibly Damaging

0.998

Probably Damaging

Deleterious

rs368003192

R810L

0.5

Possibly Damaging

0.996

Probably Damaging

Deleterious

rs769767782

V132L

0.5

Possibly Damaging

0.979

Probably Damaging

Neutral

rs1301599599

V32M

0.27

Possibly Damaging

0.996

Probably Damaging

Deleterious

rs199561420

S441L

0.5

Probably Benign

0.972

Probably Damaging

Neutral

rs56101219

I722V

0.27

Possibly Damaging

0.994

Probably Damaging

Deleterious

rs61734367

N361D

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs775401427

P49S

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs754342091

Y98C

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs765289408

S105C

0.19

Possibly Damaging

0.998

Probably Damaging

Deleterious

rs972966550

L511W

0.5

Probably Benign

0.996

Probably Damaging

Deleterious

rs1445128804

G765D

0.5

Possibly Damaging

0.996

Probably Damaging

Neutral

rs1480203162

L375F

0.5

Possibly Damaging

0.997

Probably Damaging

Deleterious

rs1480203162

L335F

0.5

Possibly Damaging

0.719

Probably Damaging

Deleterious

rs954875750

F237S

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs917000574

G279S

0.5

Possibly Damaging

0.993

Probably Damaging

Neutral

rs1256844267

T756P

0.5

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs780472681

S762I

0.5

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs762746728

L307F

0.5

Possibly Damaging

0.995

Probably Damaging

Neutral

rs1353182806

G726S

0.5

Possibly Damaging

0.998

Probably Damaging

Neutral

rs56380595

P823T

0.27

Possibly Damaging

0.999

Probably Damaging

Neutral

rs897794510

S207C

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs902036821

D194N

0.5

Possibly Damaging

0.978

Probably Damaging

Neutral

rs1314441656

Q430P

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1216019140

C340W

0.19

Possibly Damaging

0.997

Probably Damaging

Deleterious

rs2770144

V310G

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs202114774

L519V

0.5

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs199632399

R745C

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs766243776

N309Y

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs748810494

V134A

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs202040652

T793I

0.5

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs199930089

G715S

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs988829747

I742T

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs201897073

I146T

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs919321567

L372Q

0.27

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs1394250328

I742F

0.5

Probably Benign

0.978

Probably Damaging

Neutral

rs376443096

D428N

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs1382563975

V716M

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs373109368

L182V

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs1388911129

L779F

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs200139449

G803V

0.27

Probably Benign

1

Probably Damaging

Deleterious

rs1346126850

N481D

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs776282454

G699R

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1157906794

G715V

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs200905500

R787H

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs377719663

Y709C

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs892362464

L59M

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs201521400

F237L

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs199763503

L658R

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1194635312

Y674C

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs754642038

V736A

0.27

Possibly Damaging

1

Probably Damaging

Neutral

rs777803994

L802Q

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs1363147767

G252S

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs1194292799

S455T

0.27

Possibly Damaging

0

Probably Damaging

Deleterious

rs1194292799

S415T

0.27

Probably Benign

1

Benign

Deleterious

rs80197996

L470F

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs200787883

F492V

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs55905951

A676G

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs761598705

H708R

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs750790595

R787C

0.5

Possibly Damaging

0.999

Probably Damaging

Neutral

rs769239861

R87S

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs56302444

I93V

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs370421152

V134M

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs188543451

L138P

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs993554067

L208F

0.74

Possibly Damaging

0.999

Probably Damaging

Deleterious

rs2770145

C306W

0.27

Probably Damaging

1

Probably Damaging

Deleterious

rs770682940

N361K

0.5

Probably Benign

0.999

Probably Damaging

Deleterious

rs765968259

N721S

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1258063271

A754V

0.5

Possibly Damaging

0.126

Probably Damaging

Deleterious

rs748382304

I769T

0.5

Possibly Damaging

1

Benign

Neutral

rs55751501

A814T

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1301599599

V32L

0.74

Possibly Damaging

1

Probably Damaging

Deleterious

rs201613484

L104F

0.5

Probably Damaging

1

Probably Damaging

Deleterious

rs200168998

I162T

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs77214890

D181Y

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs759469467

I187S

0.27

Possibly Damaging

1.000

Probably Damaging

Deleterious

rs1440077974

L233S

0.74

Probably Benign

1

Probably Damaging

Deleterious

rs777887873

L401Q

0.74

Probably Damaging

1

Probably Damaging

Deleterious

rs777887873

L401P

0.5

Probably Damaging

0.534

Probably Damaging

Deleterious

rs201792813

Y652C

0.5

Possibly Damaging

1

Possibly Damaging

Neutral

rs751229651

V678A

0.27

Possibly Damaging

1

Probably Damaging

Deleterious

rs751229651

V638A

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs779420060

W687R

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1174477453

V688L

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1282672274

G699V

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs56101219

I722F

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs746352626

G726D

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs746352626

G726V

0.5

Possibly Damaging

1.000

Probably Damaging

Deleterious

rs1287623116

S744G

0.5

Possibly Damaging

1

Probably Damaging

Neutral

rs1048072828

T793A

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs779025130

C40Y

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs868027365

D84N

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs760962514

D84A

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1044303225

C88R

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs766539584

L152V

0.74

Possibly Damaging

1

Probably Damaging

Deleterious

rs537921846

N160S

0.5

Possibly Damaging

0.258

Probably Damaging

Deleterious

rs1281579352

P168H

0.5

Possibly Damaging

0.999

Benign

Neutral

rs1296130154

N185S

0.74

Possibly Damaging

1

Probably Damaging

Deleterious

rs371871286

N213K

0.27

Probably Damaging

1

Probably Damaging

Deleterious

rs371871286

N173K

0.5

Probably Benign

1

Probably Damaging

Deleterious

rs202089517

S407T

0.74

Possibly Damaging

1

Probably Damaging

Deleterious

rs934780727

N409S

0.5

Probably Damaging

1

Probably Damaging

Deleterious

rs764148809

L452R

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs201456149

D453G

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1285033378

C585Y

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1354283847

C609Y

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs1233324596

C609W

0.5

Possibly Damaging

1

Probably Damaging

Deleterious

rs200497661

R731Q

0.5

Possibly Damaging

0.877

Probably Damaging

Neutral


    1.  Association of nsSNPs with disease

Using SNP &Go, SuSpect, and Meta SNP, the phenotypic impact of nsSNPs on the TLR4 gene was predicted (Table 3). SNP &Go identified 118 substitutions as neutral and 14 as disease-associated. The Meta SNP server also linked 90 SNPs to diseases and identified 42 as neutral. SuSpect predicted 132 nsSNPs as disease-causing. Any SNP marked as neutral by these tools was excluded from further analysis. Functional analysis of the remaining 132 nsSNPs showed that they have deleterious, probably damaging, or disease-causing effects on the TLR4 protein. Using the i-stable tool, which assesses changes in protein thermal stability, 111 SNPs were found to reduce stability, while 21 SNPs showed an increase in stability.


Table 3. Prediction of disease associated nsSNPs and Protein Stability change prediction

Variation ID

Mutation

SNP & GO

SuSpect

Meta SNP

i stable

   

Score

Effect

Score

Score

Effect

Stability

Conf. score

rs1383009042

P145L

9

Neutral

54

0

Neutral

Decrease

0.800778

rs755813457

I320T

9

Neutral

88

3

Neutral

Decrease

0.875835

rs55786277

R804W

1

Neutral

85

6

Disease

Decrease

0.735661

rs137853920

C281Y

6

Neutral

79

5

Neutral

Increase

0.761752

rs200246890

N205H

10

Neutral

70

1

Neutral

Decrease

0.807955

rs199930089

G715R

2

Disease

91

9

Disease

Increase

0.59246

rs1044303225

V32A

9

Neutral

42

6

Neutral

Decrease

0.831297

rs1038463767

V735F

7

Neutral

78

1

Disease

Decrease

0.862233

rs1416546558

N690S

8

Neutral

60

0

Neutral

Decrease

0.889097

rs773429738

L335I

6

Neutral

77

1

Neutral

Increase

0.519921

rs757953593

I247T

8

Neutral

77

7

Neutral

Decrease

0.824498

rs1159116911

T151I

8

Neutral

84

2

Neutral

Decrease

0.82995

rs201114738

S381G

9

Neutral

79

0

Neutral

Decrease

0.863368

rs1163840909

E31V

9

Neutral

54

5

Neutral

Decrease

0.838044

rs370421152

V134L

9

Neutral

49

2

Neutral

Decrease

0.509748

rs762970720

V736L

7

Neutral

89

2

Neutral

Decrease

0.86035

rs1472004859

L117S

5

Neutral

81

1

Disease

Decrease

0.835144

rs199666264

R257P

4

Neutral

68

3

Disease

Decrease

0.758715

rs55799839

L260P

4

Neutral

59

0

Disease

Decrease

0.783652

rs1235644534

N44H

8

Neutral

62

1

Disease

Decrease

0.847527

rs759420110

L571I

7

Neutral

55

1

Neutral

Decrease

0.605933

rs749872850

E685G

5

Neutral

83

4

Disease

Decrease

0.895556

rs747209292

K694N

6

Neutral

77

0

Disease

Decrease

0.810386

rs201835255

R257C

6

Neutral

65

0

Disease

Decrease

0.764912

rs766151559

F516I

5

Neutral

91

1

Disease

Decrease

0.530973

rs368003192

R810L

1

Neutral

88

4

Disease

Decrease

0.723851

rs769767782

V132L

8

Neutral

52

2

Neutral

Decrease

0.907118

rs1301599599

V32M

9

Neutral

42

6

Neutral

Decrease

0.814225

rs199561420

S441L

8

Neutral

62

0

Neutral

Increase

0.767198

rs56101219

I722V

9

Neutral

83

0

Neutral

Decrease

0.857769

rs61734367

N361D

8

Neutral

83

3

Neutral

Increase

0.575585

rs775401427

P49S

6

Neutral

93

4

Disease

Decrease

0.76392

rs754342091

Y98C

5

Neutral

59

3

Disease

Increase

0.801449

rs765289408

S105C

7

Neutral

86

4

Disease

Increase

0.60583

rs972966550

L511W

8

Neutral

93

3

Disease

Decrease

0.570666

rs1445128804

G765D

6

Neutral

46

0

Disease

Decrease

0.824948

rs1480203162

L375F

9

Neutral

93

1

Neutral

Decrease

0.780765

rs1480203162

L335F

6

Neutral

88

1

Disease

Decrease

0.873495

rs954875750

F237S

7

Neutral

62

1

Disease

Decrease

0.782778

rs917000574

G279S

9

Neutral

48

4

Neutral

Decrease

0.829709

rs1256844267

T756P

0

Disease

76

6

Disease

Decrease

0.776527

rs780472681

S762I

3

Neutral

64

5

Disease

Increase

0.861936

rs762746728

L307F

8

Neutral

71

6

Neutral

Decrease

0.764051

rs1353182806

G726S

6

Neutral

52

0

Neutral

Decrease

0.726902

rs56380595

P823T

5

Neutral

45

2

Disease

Decrease

0.829011

rs897794510

S207C

9

Neutral

71

2

Disease

Increase

0.521313

rs902036821

D194N

8

Neutral

68

7

Neutral

Decrease

0.794228

rs1314441656

Q430P

7

Neutral

65

5

Disease

Decrease

0.758183

rs1216019140

C340W

7

Neutral

85

5

Disease

Decrease

0.53435

rs2770144

V310G

7

Neutral

74

2

Disease

Decrease

0.872542

rs202114774

L519V

9

Neutral

92

1

Neutral

Decrease

0.75702

rs199632399

R745C

3

Neutral

73

6

Disease

Decrease

0.82176

rs766243776

N309Y

7

Neutral

84

1

Disease

Increase

0.580148

rs748810494

V134A

9

Neutral

41

4

Neutral

Decrease

0.843255

rs202040652

T793I

1

Neutral

88

0

Neutral

Decrease

0.769871

rs199930089

G715S

0

Neutral

92

7

Disease

Decrease

0.767046

rs988829747

I742T

4

Neutral

90

3

Disease

Decrease

0.803838

rs201897073

I146T

7

Neutral

85

2

Disease

Decrease

0.868333

rs919321567

L372Q

8

Neutral

95

3

Disease

Decrease

0.662393

rs1394250328

I742F

2

Neutral

77

2

Disease

Decrease

0.788934

rs376443096

D428N

9

Neutral

54

6

Neutral

Increase

0.531709

rs1382563975

V716M

7

Neutral

58

1

Disease

Decrease

0.777009

rs373109368

L182V

8

Neutral

92

1

Neutral

Decrease

0.790967

rs1388911129

L779F

8

Neutral

89

2

Disease

Decrease

0.833589

rs200139449

G803V

4

Neutral

51

4

Disease

Decrease

0.556804

rs1346126850

N481D

4

Neutral

97

5

Disease

Decrease

0.644177

rs776282454

G699R

7

Neutral

27

4

Disease

Decrease

0.788658

rs1157906794

G715V

1

Disease

88

8

Disease

Decrease

0.531214

rs200905500

R787H

6

Neutral

69

3

Disease

Decrease

0.875812

rs377719663

Y709C

4

Neutral

87

6

Disease

Decrease

0.861331

rs892362464

L59M

8

Neutral

97

2

Disease

Decrease

0.835298

rs201521400

F237L

9

Neutral

57

1

Neutral

Decrease

0.761194

rs199763503

L658R

0

Disease

65

4

Disease

Decrease

0.856749

rs1194635312

Y674C

0

Disease

79

7

Disease

Decrease

0.759093

rs754642038

V736A

4

Neutral

98

3

Disease

Decrease

0.863389

rs777803994

L802Q

5

Neutral

24

0

Neutral

Decrease

0.847852

rs1363147767

G252S

9

Neutral

37

7

Neutral

Decrease

0.804551

rs1194292799

S455T

6

Neutral

72

0

Disease

Decrease

0.779176

rs1194292799

S415T

9

Neutral

52

5

Neutral

Increase

0.709602

rs80197996

L470F

4

Neutral

83

2

Disease

Decrease

0.652258

rs200787883

F492V

3

Neutral

95

3

Disease

Increase

0.603573

rs55905951

A676G

6

Neutral

79

2

Disease

Decrease

0.808704

rs761598705

H708R

0

Disease

90

6

Disease

Increase

0.697562

rs750790595

R787C

2

Neutral

80

5

Disease

Decrease

0.858065

rs769239861

R87S

8

Neutral

37

1

Neutral

Decrease

0.702746

rs56302444

I93V

9

Neutral

89

4

Neutral

Decrease

0.884007

rs370421152

V134M

9

Neutral

46

2

Neutral

Decrease

0.826485

rs188543451

L138P

1

Neutral

97

5

Disease

Decrease

0.806341

rs993554067

L208F

6

Neutral

81

2

Disease

Decrease

0.604569

rs2770145

C306W

7

Neutral

66

0

Disease

Decrease

0.751925

rs770682940

N361K

6

Neutral

87

1

Disease

Decrease

0.66961

rs765968259

N721S

6

Neutral

81

2

Disease

Decrease

0.554849

rs1258063271

A754V

3

Neutral

94

3

Disease

Decrease

0.801621

rs748382304

I769T

4

Neutral

98

5

Disease

Decrease

0.812199

rs55751501

A814T

6

Neutral

90

2

Disease

Decrease

0.872272

rs1301599599

V32L

9

Neutral

39

7

Neutral

Decrease

0.675548

rs201613484

L104F

8

Neutral

99

5

Disease

Decrease

0.846026

rs200168998

I162T

6

Neutral

95

4

Disease

Decrease

0.763441

rs77214890

D181Y

7

Neutral

75

2

Disease

Increase

0.664035

rs759469467

I187S

2

Neutral

97

3

Disease

Decrease

0.885339

rs1440077974

L233S

5

Neutral

83

2

Disease

Decrease

0.878476

rs777887873

L401Q

3

Neutral

98

5

Disease

Decrease

0.800966

rs777887873

L401P

1

Disease

98

5

Disease

Decrease

0.800863

rs201792813

Y652C

3

Neutral

85

7

Disease

Decrease

0.773517

rs751229651

V678A

1

Neutral

91

5

Disease

Increase

0.576001

rs751229651

V638A

8

Neutral

59

1

Neutral

Decrease

0.85106

rs779420060

W687R

2

Neutral

96

9

Disease

Decrease

0.798396

rs1174477453

V688L

5

Neutral

90

2

Disease

Decrease

0.735517

rs1282672274

G699V

4

Neutral

59

4

Disease

Decrease

0.810926

rs56101219

I722F

2

Neutral

93

5

Disease

Decrease

0.841606

rs746352626

G726D

1

Neutral

88

6

Disease

Decrease

0.6951

rs746352626

G726V

3

Neutral

70

4

Disease

Decrease

0.697765

rs1287623116

S744G

5

Neutral

93

5

Disease

Decrease

0.82433

rs1048072828

T793A

4

Neutral

92

2

Disease

Decrease

0.792187

rs779025130

C40Y

5

Disease

96

6

Disease

Increase

0.651774

rs868027365

D84N

8

Neutral

71

0

Neutral

Decrease

0.710009

rs760962514

D84A

6

Neutral

90

3

Disease

Decrease

0.66321

rs1044303225

C88R

6

Disease

96

8

Disease

Increase

0.5

rs766539584

L152V

7

Neutral

94

0

Neutral

Decrease

0.835198

rs537921846

N160S

2

Neutral

98

3

Disease

Increase

0.61148

rs1281579352

P168H

7

Neutral

73

3

Disease

Decrease

0.811214

rs1296130154

N185S

4

Neutral

98

0

Disease

Decrease

0.805635

rs371871286

N213K

6

Neutral

88

3

Disease

Increase

0.593595

rs371871286

N173K

9

Neutral

73

1

Neutral

Decrease

0.781762

rs202089517

S407T

9

Neutral

63

6

Neutral

Decrease

0.672228

rs934780727

N409S

5

Neutral

94

1

Disease

Decrease

0.8161

rs764148809

L452R

1

Disease

92

5

Disease

Decrease

0.817242

rs201456149

D453G

1

Neutral

86

2

Disease

Decrease

0.759654

rs1285033378

C585Y

5

Disease

99

9

Disease

Increase

0.791755

rs1354283847

C609Y

3

Disease

98

9

Disease

Decrease

0.709539

rs1233324596

C609W

4

Disease

98

9

Disease

Decrease

0.693086

rs200497661

R731Q

3

Disease

91

4

Disease

Decrease

0.804204


Additionally, a comparison of 82 highly conserved mutations in TLR4 proteins was conducted using 10 bioinformatic tools to identify potential conformational changes (Table 4). These analyses provide valuable insights into the potential effects of these SNPs on the TLR4 protein and its function.

       
            3D Model of TLR4 gene.png
       

Figure 4. 3D Model of TLR4 gene

3.5 Homology modeling and validation of structure

The 3D model of the TLR4 protein was created using a template from the Swiss Model, as the PDB model with ID 5NAO was not fully available. The Swiss Model identified 50 templates, with a 99.64% sequence identity to the query sequence, corresponding to the STML ID Q9TTN0.1.A. This template was used to construct a more complete model of TLR4, focusing on the sequence from amino acids 1 to 839. Specifically, the Alphafold DB model of TLR4_PANPA (gene: TLR4, organism: Pan paniscus) was used for the query sequence. The model's quality and the resulting structure, created using PyMol, are displayed in Figure 4. This 3D model provides a more accurate representation of the TLR4 protein, allowing for further investigation into the impact of mutations on its stability. The TLR4 protein model was refined using GalaxyRefine, resulting in the selection of model 05 as the most refined version. The model's quality was evaluated using QMEAN, yielding a Z-score of -0.81, and a ProSA score was -7.51, both of which were compared to experimental structures of similar size. The final structure adhered to all potential energy calculation constraints, with the majority of amino acid residues (99.64%) located in favorable regions of the RAMACHANDRAN plot. A negative QMEAN Z-score suggests that the protein structure may be unstable. In Figure 5, the refined TLR4 model is highlighted with a red star, indicating its significance and the structural assessment based on these quality metrics. These findings suggest that while the model is refined, it may require further investigation to confirm its stability.

       
            Procheck-RAMACHANDRAN plot a.  QMEAN of the native TLR4 predicted model b ProSA plot.png
       

Figure 5. Procheck-RAMACHANDRAN plot (a).  QMEAN of the native TLR4 predicted model (b) ProSA plot.

The E31V, R257P, L260P, N44H, R257C, P49S, F237S, S207C, I146T, L182V, L59M, L138P, L208F, I162T, D181Y, I187S, L233S, C40Y, D84A, C88R, N160S, N185S, N213K showed high RMSD values, indicating significant structural changes. SAVES was used to validate the modeled structures, and a RAMACHANDRAN plot analysis was performed to assess the secondary structure of the proteins. The full set of predicted outcomes, including specific details, is provided in Table 2. These results indicate that the modeled mutant proteins are structurally sound, with the majority of residues occupying stable conformations.


Table 4. Structural validation and comparison of TLR4 gene

Variation ID

Mutation

ERRAT

Procheck

Verify

TM Align

Score

Core

Allow

Score

Tm Score

RMSD

Model

92.3274

0.825

0.152

0.7521

   

rs755813457

I320T

88.8748

0.9

0.095

0.7402

0.99852

0.38

rs55786277

R804W

88.539

0.895

0.096

0.7271

0.99845

0.39

rs199930089

G715R

88.0503

0.889

0.105

0.7437

0.99821

0.42

rs1159116911

T151I

91.2989

0.887

0.104

0.7652

0.99842

0.39

rs1163840909

E31V

88.7768

0.896

0.096

0.7664

0.99849

0.38

rs1472004859

L117S

89.8862

0.899

0.093

0.7509

0.99843

0.39

rs199666264

R257P

90.0504

0.89

0.1

0.7449

0.99842

0.39

rs55799839

L260P

86.22

0.901

0.092

0.7521

0.99841

0.39

rs1235644534

N44H

87.8635

0.897

0.093

0.7735

0.99832

0.41

rs749872850

E685G

91.1504

0.893

0.1

0.7342

0.99837

0.4

rs747209292

K694N

91.5723

0.89

0.105

0.7485

0.99846

0.39

rs201835255

R257C

90.6566

0.89

0.103

0.7318

0.99854

0.38

rs766151559

F516I

92.9114

0.886

0.102

0.7592

0.99851

0.38

rs368003192

R810L

89.029

0.894

0.098

0.7461

0.99824

0.42

rs775401427

P49S

90.2408

0.897

0.096

0.7735

0.99838

0.4

rs754342091

Y98C

89.1414

0.892

0.096

0.7449

0.99839

0.4

rs972966550

L511W

89.3805

0.891

0.098

0.758

0.99841

0.39

rs1480203162

L335F

88.6076

0.894

0.098

0.7592

0.99837

0.4

rs954875750

F237S

87.6106

0.891

0.102

0.7557

0.99842

0.39

rs1256844267

T756P

90.7828

0.898

0.091

0.7497

0.99837

0.4

rs897794510

S207C

90.4403

0.894

0.099

0.7461

0.99828

0.41

rs1314441656

Q430P

87.9093

0.886

0.102

0.7557

0.99831

0.41

rs1216019140

C340W

90.2408

0.891

0.1

0.7449

0.99835

0.4

rs2770144

V310G

85.7503

0.894

0.097

0.7664

0.99835

0.4

rs199632399

R745C

89.3671

0.904

0.088

0.764

0.99847

0.39

rs199930089

G715S

88.1313

0.887

0.105

0.7461

0.9983

0.41

rs988829747

I742T

85.335

0.887

0.105

76.52%

0.99834

0.4

rs201897073

I146T

90.404

0.894

0.101

75.21%

0.99837

0.4

rs919321567

L372Q

88.5101

0.898

0.097

0.7712

0.99836

0.4

rs1394250328

I742F

90.4282

0.894

0.096

0.7557

0.99843

0.39

rs1382563975

V716M

87.3897

0.903

0.091

0.7747

0.99843

0.39

rs373109368

L182V

89.3671

0.891

0.1

0.7676

0.99836

0.4

rs1388911129

L779F

90.1141

0.899

0.092

0.7497

0.9984

0.4

rs200139449

G803V

90.5303

0.893

0.101

0.7485

0.99848

0.38

rs1346126850

N481D

90.7712

0.886

0.105

0.7592

0.99835

0.4

rs776282454

G699R

90.7945

0.898

0.092

0.7676

0.99847

0.39

rs1157906794

G715V

88.7768

0.9

0.094

0.7616

0.99836

0.4

rs200905500

R787H

87.6419

0.889

0.106

0.7783

0.99838

0.4

rs377719663

Y709C

88.3838

0.887

0.102

0.7652

0.99839

0.4

rs892362464

L59M

88.3692

0.889

0.101

0.7342

0.99839

0.4

rs199763503

L658R

90.3676

0.89

0.102

0.7569

0.9985

0.38

rs1194635312

Y674C

89.0428

0.898

0.097

0.7485

0.99845

0.39

rs777803994

L802Q

89.8734

0.891

0.098

0.7426

0.99839

0.4

rs1194292799

S455T

88.1013

0.887

0.101

0.7652

0.99837

0.4

rs80197996

L470F

89.5202

0.894

0.093

0.7414

0.99835

0.4

rs55905951

A676G

87.3578

0.894

0.097

0.764

0.99846

0.39

rs188543451

L138P

87.6904

0.896

0.093

0.7664

0.99841

0.39

rs993554067

L208F

90.4943

0.892

0.1

0.7533

0.99833

0.4

rs2770145

C306W

90.9091

0.896

0.096

0.7473

0.99854

0.38

rs770682940

N361K

90.3797

0.9

0.091

0.7509

0.99853

0.38

rs765968259

N721S

88.5932

0.896

0.095

0.7569

0.99833

0.4

rs1258063271

A754V

89.7856

0.894

0.1

0.7664

0.99833

0.4

rs55751501

A814T

89.8515

0.892

0.101

0.745

0.97484

0.8

rs201613484

L104F

92.0354

0.894

0.101

0.7676

0.99833

0.4

rs200168998

I162T

90.2532

0.885

0.106

0.7569

0.99852

0.38

rs77214890

D181Y

88.8466

0.883

0.108

0.7878

0.99851

0.38

rs759469467

I187S

90.5542

0.896

0.093

0.7604

0.99834

0.4

rs1440077974

L233S

88.0503

0.903

0.085

0.7723

0.99846

0.39

rs777887873

L401Q

86.185

0.891

0.101

0.7437

0.99839

0.4

rs777887873

L401P

89.2132

0.891

0.1

0.7604

0.99851

0.38

rs751229651

V638A

89.2677

0.899

0.097

0.7533

0.99835

0.4

rs779420060

W687R

89.0013

0.889

0.104

0.7521

0.99835

0.4

rs1174477453

V688L

89.2541

0.899

0.093

74.85%

0.99848

0.39

rs1282672274

G699V

89.0704

0.895

0.098

0.7545

0.99831

0.41

rs56101219

I722F

89.2405

0.894

0.097

0.7652

0.99837

0.4

rs746352626

G726D

91.7513

0.895

0.096

0.733

0.99848

0.38

rs746352626

G726V

90.3023

0.898

0.094

0.7414

0.99828

0.41

rs1048072828

T793A

88.2724

0.891

0.101

0.7604

0.99857

0.37

rs779025130

C40Y

86.6162

0.895

0.096

0.7616

0.99838

0.4

rs760962514

D84A

89.029

0.891

0.104

0.7807

0.9983

0.41

rs1044303225

C88R

90.2655

0.894

0.096

0.7664

0.99835

0.4

rs537921846

N160S

89.2541

0.891

0.102

0.7557

0.99838

0.4

rs1296130154

N185S

89.4207

0.891

0.098

0.7545

0.99828

0.41

rs371871286

N213K

87.6263

0.896

0.097

0.7664

0.9983

0.41

rs371871286

N173K

85.8407

0.883

0.106

0.7449

0.99845

0.39

rs934780727

N409S

86.9289

0.89

0.104

0.7533

0.99859

0.37

rs764148809

L452R

88.0051

0.882

0.108

0.7497

0.99832

0.41

rs201456149

D453G

85.5528

0.887

0.105

0.7688

0.99844

0.39

rs1285033378

C585Y

89.0428

0.891

0.098

0.7426

0.99834

0.4

rs1354283847

C609Y

85.9316

0.891

0.1

0.7461

0.99854

0.38

rs1233324596

C609W

90.621

0.899

0.091

0.7878

0.99845

0.39

rs200497661

R731Q

90.2655

0.887

0.102

0.7497

0.99851

0.38


3.6 Structural effect of mutations

Mutation 3D predicts the potential impact of amino acid substitutions on protein structures, as outlined in Table 5. Mutations that are clustered are represented in red, while covered mutations are shown in blue. This visualization helps to distinguish the different types of mutations based on their location and potential structural consequences.


Table 5. Functional prediction of TLR4 protein by Mutation 3D

Variation ID

Mutation

Mutation 3D    Prediction

rs1163840909

E31V

Covered

rs199666264

R257P

Clustered

rs55799839

L260P

Clustered

rs1235644534

N44H

Covered

rs201835255

R257C

Clustered

rs775401427

P49S

Covered

rs954875750

F237S

Clustered

rs897794510

S207C

Clustered

rs201897073

I146T

Clustered

rs373109368

L182V

Clustered

rs892362464

L59M

Covered

rs188543451

L138P

Covered

rs993554067

L208F

Clustered

rs200168998

I162T

Covered

rs77214890

D181Y

Clustered

rs759469467

I187S

Covered

rs1440077974

L233S

Clustered

rs779025130

C40Y

Covered

rs760962514

D84A

Covered

rs1044303225

C88R

Covered

rs537921846

N160S

Clustered

rs1296130154

N185S

Clustered

rs371871286

N213K

Clustered


Moreover, HOPE predicted the impact of 12 variants on the hydrophobicity, spatial structure, physical and chemical characteristics, and function of the KRT74 protein. According to HOPE, the mutant residue N44H is larger than the wild-type residue, while the mutant residues D84A and N185S are smaller than the wild-type. The effect of the D84A mutation on the protein is considered probably damaging. The location of the N44H mutation is within the protein's domain, while D84A is located in or near highly conserved regions. The S207C mutation is found at homologous sequences, and its effect is predicted to be possibly damaging (Figure 6).

       
            Structural changes of mutant highlighted by HOPE Project.png
       

Figure 6. Structural changes of mutant highlighted by HOPE Project.

    1.  Protein-ligand docking analysis

PyRx program utilized molecular docking to examine ligand-protein interactions, docking 16 selected ligands with TLR4. The binding affinities of these ligands correlate with their activity levels, and all 16 compounds with their respective binding affinities are listed in Table 6. From this, 5 compounds with strong binding affinities (high binding scores) Apigenin, Tetracycline, Tetrodotoxin, S-adenosylmethionine, and Vixotrigine were selected and docked with the native TLR4 protein. For further analysis, Discovery Studio was used, which provides a two-dimensional representation of each docking interaction.


Table 6. Interpretation of docking score highlighted by PyRx between ligands and native protein.

Ligands

Model

Ligands

Model

Apigenin

-6.5

SYUIQ-5

-6.1

GAG

-4.8

Tamoxifen

-5.7

GN8

-5.9

Tetrodotoxin

-6.4

Riluzole

-4.9

S-adenosylmethionine

-6.3

Sclareol

-5.3

Vixotrigine

-7.1

Statin

-5.5

Topiramate

-5.5

Sinularin

-5.8

Thymol

-4.7

Tetracycline

-7

Thymoquione

-4.9


Every ligand selected for docking had a binding free energy greater than -4 kcal/mol, as shown in Table 4. The highest binding energy revealed that the TLR4 protein was successfully docked with Vixotrigine. Vixotrigine and Tetracycline showed the highest binding affinities of -7.1 and -7.0 kcal/mol, respectively, which exceed the affinities of conventional ligand-binding. The Apigenin ligand was fixed in the TLR4 binding pocket sites through conventional Van der Waals interactions with TYR403, GLU376, ARG355, GLU425, ILE450, and TYR451. The Tetracycline ligand was fixed in the TLR4 binding pocket sites through Van der Waals interactions with ASN433, HIS458, THR457, THR459, MET437, LYS435, GLU439, and ALA465. The Tetrodotoxin ligand was fixed in the TLR4 binding pocket sites via Van der Waals interactions with ALA462, MET437, SER438, LEU434, ASN433, GLU439, THR457, and THR459. The S-adenosylmethionine ligand was fixed in the TLR4 binding pocket sites via Van der Waals interactions with ALA610, ASN554, PHE581, LEU553, ARG606, and GLN505. The Vixotrigine ligand was fixed in the TLR4 binding pocket sites through Van der Waals interactions with MET607, PHE581, ALA610, ASP580, LEU553, ASN531, ASN530, and ASN554. Figure 7 displays the interacting residues discovered by docking and compares the interactions between ligand-protein residues in the mutant (N44H, S207C, D84A, N185S) and native TLR4 proteins, highlighting how the mutations alter the functional properties.

       
            Interaction of protein ligands with TLR4 with Apigenin (a), S-adenosylmethionine (b), Tetracycline.png
       

Figure 7. Interaction of protein ligands with TLR4 with Apigenin (a), S-adenosylmethionine (b), Tetracycline (c), Tetrodotoxin(d) and (e)Vixotrigine.

The ligands interact with TLR4 protein and play a critical role in modulating its function. TLR4 is involved in the innate immune response and recognizes PAMPs and DAMPs, triggering inflammation and immune activation. 1. Apigenin is known for its anti-inflammatory properties. By binding to TLR4, Apigenin may inhibit the receptor's activation, reducing the inflammatory response. Its interactions with residues like TYR403, GLU376, and ARG355 in the binding pocket can potentially interfere with the downstream signaling pathways, which could help in controlling inflammation. As an antibiotic, Tetracycline can modulate immune responses by interacting with TLR4. It may reduce TLR4-mediated signaling by binding to the receptor and disrupting its function. This could be useful in mitigating excessive immune activation, which is often observed in chronic inflammation and autoimmune diseases. Tetrodotoxin is a potent neurotoxin that blocks sodium channels. Its binding to TLR4 may modulate immune responses by influencing TLR4 signaling, potentially altering the activation of inflammatory pathways. The exact effect of Tetrodotoxin on TLR4 signaling is not fully understood but may involve the inhibition of TLR4-mediated immune responses. S-adenosylmethionine (SAM) is a key molecule involved in methylation reactions and has anti-inflammatory properties. It may modulate TLR4 activity by regulating its signaling pathways, possibly through epigenetic modifications. Its interaction with residues like ALA610, ASN554, and PHE581 may affect the receptor's ability to respond to inflammatory stimuli, thereby reducing the immune response. Vixotrigine, a sodium channel blocker, may have an effect on TLR4-mediated signaling, particularly in inflammatory diseases. Its binding with residues such as MET607, PHE581, and ALA610 could impact the receptor's conformation and reduce the activation of inflammatory pathways, making it a potential therapeutic agent for conditions involving TLR4-driven inflammation. In summary, these ligands can interact with TLR4, potentially altering its structure and function. By either inhibiting or modulating the TLR4 signaling pathway, they may serve as therapeutic agents for diseases driven by excessive or chronic inflammation. The effectiveness of these compounds is further supported by their strong binding affinities and specific interactions with key residues of the TLR4 receptor.

DISCUSSION

Conjunctivitis is a common ophthalmic disease that causes inflammation of the conjunctival tissues. Clinical symptoms include increased discharge, conjunctival congestion, photophobia, and itchy sensations [36]. The nsSNPs are single base variations that alter the encoded protein's amino acid sequence. Studies have examined how nsSNPs affect specific proteins, such as stability and the active sites of enzymes. These investigations 53 examine the different ways that nsSNPs may impact interactions between proteins. Before examining the investigation of nsSNPs from a network viewpoint, we focus on structural alterations that might hinder interaction, changes to disorder, gain of interaction, and post-translational modifications. Here are some instances of nsSNPs at human-pathogen protein-protein interfaces [37].Toll-like receptor 4 (TLR4), expressed in various cells, forms the foundation of the mammalian innate immune system, which is characterized by malfunctioning in different situations [38]. TLR4 SNP is linked to various diseases and dysfunctions in patient populations. TLR4 targeting may not be a cure, impacting drug use and polypharmacy. Its flexibility in binding to various ligands contributes to its flexibility [38]. The study identified 132 missense mutations common in SIFT and Polyhen databases, 82 nsSNPs using 10 repository tools, and analyzed high RMSD mutants using TM align for structural effects. We use computational tools to analyze molecular docking studies to predict protein-ligand interaction and analyze diseases causing SNPs and their impact on protein stability. The study utilized various prediction tools to analyze pathogenic nsSNPs of the TLR4 gene, revealing that 96 out of 132 nsSNPs may be harmful, with 28 SNP variants likely to be benign The predicted SNPs revealed that 104 out of 132 nsSNPs had a negative effect, 28 were neutral, and all 128 SNPs were likely to be damaging. Apart from the possibly damaged Y652C, the benign S415T, I769T, and P168H are also present. SNP &G0 prediction shows that 14 of the 118 substitutions are neutral and linked to illness. The Meta SNP database identified 42 neutral nsSNPs and 90 disease nsSNPs. SuSpect found 132 nsSNPs associated with the disease. Functional analysis revealed that the TLR4 gene has detrimental, potentially damaging effects and a disease effect. These 132 nsSNPs were used to predict the effect of the gene on protein stability. The 132 disease-associated nsSNPs were put in the I-stable to evaluate their effect on protein stability. Since I-stable predicts changes in protein thermal stability, 24 nsSNPs indicated increasing stability and 111 nsSNPs showed decreasing protein thermal stability. Out of 82 nsSNPs in SAVES, 82 mutations were analyzed, but 22 results were shown by 3D mutation. Utilizing a mutation 3D tool, we analyze the functional impact of genetic mutations on disease mechanisms, gene function, and personalized medicine, predicting potential protein function impacts.Out of 82 mutations, we find 1 uncovered mutation, 13 clustered mutations, and 10 covered mutations based on mutation 3D. A more thorough analysis of the 132 nsSNPs is conducted for structural validation. The experimental model for a higher-quality targeted protein structure was validated using various computational programs like TM-Align, verify 3D, SWISS-MODEL, PROCHECK, QMEAN, and ERRAT. The server produced 132 templates, 1 of which was Q9TTN0.1.A., based on the best-aligned template. Our targeted protein's whole sequence was covered by a toll-like receptor. The model, interestingly, fell within the amino acid range of 839, which may be 56 suggesting that the protein sequence surrounding this region is conserved. The Ramachandran plot is a crucial verification matrix as it displays the ?-? torsion angles of the predicted protein backbone. PROCHECK divides the Ramachandran plot into four regions: core, allowed, generously allowed, and disallowed. This allows it to estimate the stereochemical quality of a particular protein structure. The Ramachandran plot's preferred region is described by SWISS-MODEL. Over 90% of core or most favored residues in protein models can be identified with a favorable structure, with scores provided by other computational tools. A QMEAN-Z score of -4.0 or less denotes a low-quality model, while a higher score identifies favorable structural states. Using the TM-align tool, a structural comparison between the wild-type and mutant structures was examined. A high RMSD value and a low TM score both point to structural dissimilarity. The Swiss model indicates that the generated structure is of good quality and suitable for protein-ligand studies. For additional examination, one model and four mutated proteins were chosen based on the validation software's standard score. The PyRx Autodock vina 0.4 software was used to perform docking for 16 drugs and their 5 potential targets. It provided a docking score along with energy minimization values. Out of 16 ligands and 5 protein interactions, the molecular docking studies have revealed that the drug-target interactions of the Model-Apigenin complex were -6.5, the Model-Tetracycline complex was -7.0, the Model-Tetrodotoxin complex was -6.4, the Model-S-adenosylmethionine complex was -6.3, and the Model-Vixotrigine complex was -7.1. These results represent the highest docking scores with energy minimization. The interaction between the ligand and target complex was observed using Discovery Studio Visualizer. A protein's evolutionary conservation profile can be used to gauge how severe a harmful mutation is. 57 Further research is necessary to understand pathogenicity, protein stability, and disease-related nsSNPs. Computational tools will be used in conjunction with wet and dry lab docking analyses of nsSNPs in TLR4 to find novel medications for the treatment of conjunctivitis. When interpreting genetic test results and deciding on a course of treatment, medical professionals can gain from the clinical application of in silico analysis. Experimental research on the functional impact of nsSNPs on immune function is informed by in silico predictions because TLR4 is an essential part of the human immune system. Information about therapeutic targets and the pathophysiology of disease is provided by this method. Computation biologists, physicians, and pharmaceutical companies must collaborate to translate in silico discoveries into clinical applications. Improving patient outcomes and quality of life for people with diseases related to TLR4 is the goal.

CONCLUSION

In conclusion, through the use of various computational tools, we conducted an in-depth analysis of TLR4 gene SNPs, categorizing them based on their pathogenicity. We found 132 were classified as highly pathogenic and deleterious from 82 missense variants, while the remaining SNPs were considered likely neutral. Structural analysis revealed that these pathogenic variants cause significant disruption to the protein structure and stability, suggesting that they alter the protein function by affecting the normal 3D conformation of the TLR4 protein. Although rs897794510 exhibited similar results for mutant and wild-type sizes, HOPE modeling for variants such as rs199930089, rs1235644534, rs1282672274, rs746352626, and rs760962514 suggested that the mutant size was larger than the wild type. Variants like rs199930089, rs1282672274, and rs746352626 were identified as pathogenic and potentially harmful, while others such as rs368003192 and rs1314441656 were also considered likely harmful. Molecular docking simulations were performed using Pyrx, where the modeled structure of the TLR4 protein was docked with 16 different ligands to predict binding site conformations and ligand orientations. The compounds Vixotrigine, Tetracycline, Apigenin, Tetrodotoxin, and S-adenosylmethionine showed promising binding energy levels. Based on these findings, future research into diseases associated with conjunctivitis should focus on these nsSNPs as primary targets. Since this is the first in-silico study analyzing TLR4 gene variants, it provides a foundation for future experimental studies on diseases related to these polymorphisms. Furthermore, mutational studies could offer deeper insights into the specific functional consequences of these SNPs.

ACKNOWLEDGMENT

We all grateful to our supervisor Dr. Hamna Tariq and our mentor Kainat Ramzan for their guidance in this study.

Funding Information

No Funding

Declaration of Conflict

No Conflict of Interest.

REFERENCES

  1. Gupta, A., et al., Red Eyes—Conjunctivitis, Corneal Ulcers, Dry Eye Disease, and Acute Uveitis, in Ophthalmic Signs in Practice of Medicine. 2024, Springer. p. 493-542.
  2. Gui, S.-Y., et al., Long-term effects of meteorological factors and extreme weather on daily outpatient visits for conjunctivitis from 2013 to 2020: a time-series study in Urumqi, China. Environmental Science and Pollution Research, 2023. 30(20): p. 58041-58057.
  3. Nawaz, S., et al., The Outbreak of Highly Contagious Conjunctivitis (Pink Eye) in Major Cities of Pakistan. The Open Infectious Diseases Journal, 2024. 16(1).
  4. Petrillo, F., et al., Candida Biofilm Eye Infection: Main Aspects and Advance in Novel Agents as Potential Source of Treatment. Antibiotics, 2023. 12(8): p. 1277.
  5. Abebe, T., et al., Bacterial Profile of External Ocular Infections, Its Associated Factors, and Antimicrobial Susceptibility Pattern among Patients Attending Karamara Hospital, Jigjiga, Eastern Ethiopia. International Journal of Microbiology, 2023. 2023(1): p. 8961755.
  6. Rogers, M.S., et al., The classical pink-eyed dilution mutation affects angiogenic responsiveness. PLoS One, 2012. 7(5): p. e35237.
  7. Habib, A., et al., Rising rates of conjunctivitis in Pakistan: epidemic, challenges, solutions, and recommendations. IJS Global Health, 2024. 7(2): p. e0422.
  8. Amjad, S.S., et al., Outbreak of Conjunctivitis in South Asia: A Landscape of Current Situation and Rapid Review of Literature. IJCMCR. 2024; 39 (2). 5.
  9. Said, N., R. Fekry, and H. Elmesallmy, Association between viral Conjunctivitis and Genetic Polymorphisms related to IL-4 and IL-4R in Egyptian Population. Zagazig University Medical Journal, 2022. 28(6.2): p. 333-338.
  10. Kim, H.-J., et al., Toll-like receptor 4 (TLR4): new insight immune and aging. Immunity & Ageing, 2023. 20(1): p. 67.
  11. Manjili, F.A., A. Yousefi-Ahmadipour, and M.K. Arababadi, The roles played by TLR4 in the pathogenesis of multiple sclerosis; a systematic review article. Immunology letters, 2020. 220: p. 63-70.
  12. Wicherska-Paw?owska, K., T. Wróbel, and J. Rybka, Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases. Int J Mol Sci, 2021. 22(24).
  13. Behzadi, P., H.A. García-Perdomo, and T.M. Karpi?ski, Toll?like receptors: general molecular and structural biology. Journal of Immunology Research, 2021. 2021(1): p. 9914854.
  14. Molteni, M., S. Gemma, and C. Rossetti, The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators Inflamm, 2016. 2016: p. 6978936.
  15. Nieto, J.E., et al., Increased expression of tlr4 in circulating cd4+ t cells in patients with allergic conjunctivitis and in vitro attenuation of th2 inflammatory response by alpha-msh. International Journal of Molecular Sciences, 2020. 21(21): p. 7861.
  16. Arbour, N.C., et al., TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet, 2000. 25(2): p. 187-91.
  17. Oscanoa, J., et al., SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update). Nucleic acids research, 2020. 48(W1): p. W185-W192.
  18. Rozario, L.T., T. Sharker, and T.A. Nila, In silico analysis of deleterious SNPs of human MTUS1 gene and their impacts on subsequent protein structure and function. PloS one, 2021. 16(6): p. e0252932.
  19. Venkata Subbiah, H., P. Ramesh Babu, and U. Subbiah, In silico analysis of non-synonymous single nucleotide polymorphisms of human DEFB1 gene. Egyptian Journal of Medical Human Genetics, 2020. 21: p. 1-9.
  20. Thomas, P.D., et al., PANTHER: Making genome?scale phylogenetics accessible to all. Protein Science, 2022. 31(1): p. 8-22.
  21. Dakshitha, S., V. Suresh, and E. Dilipan, Computational exploration of single-nucleotide polymorphisms in the human hRAS gene: Implications and insights. Cureus, 2024. 16(1).
  22. Azmi, M.B., et al., Identification of potential therapeutic intervening targets by in-silico analysis of nsSNPs in preterm birth-related genes. Plos one, 2023. 18(3): p. e0280305.
  23. Hussein, Z.A. and A.A. Al-Kazaz, Bioinformatics evaluation of CRISP2 gene SNPs and their impacts on protein. Iraqi Journal of Agricultural Sciences, 2023. 54(2): p. 369-377.
  24. Mohkam, M., et al., In Silico Evaluation of Nonsynonymous SNPs in Human ADAM33: The Most Common Form of Genetic Association to Asthma Susceptibility. Computational and Mathematical Methods in Medicine, 2022. 2022(1): p. 1089722.
  25. NYIRENDA, F. and C. MEDI, DEVELOPMENT OF WEB-BASED APPLICATION FOR CRIME REPORTING AND HANDLING IN MALAWI POLICE SERVICE. I-Manager's Journal on Computer Science, 2024. 12(1).
  26. Rojas Velazquez, M.N., S. Therkelsen, and A.V. Pandey, Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays. Biomolecules, 2023. 13(12): p. 1728.
  27. Chen, C.-W., et al., iStable 2.0: Predicting protein thermal stability changes by integrating various characteristic modules. Computational and structural biotechnology journal, 2020. 18: p. 622-630.
  28. KUMAR, N., et al., Bioinformatics Tools to Study Homology Modeling. Computational Biology in Drug Discovery and Repurposing, 2024: p. 75.
  29. Muhammed, M.T. and E. Aki-Yalcin, Up-to-Date Developments in Homology Modeling. Applied Computer-Aided Drug Design: Models and Methods, 2023: p. 116.
  30. Datir, S. and P. Ghosh, In silico analysis of the structural diversity and interactions between invertases and invertase inhibitors from potato (Solanum tuberosum L.). 3 Biotech, 2020. 10(4): p. 178.
  31. Guzmán-Vega, F.J., Large Scale Approaches for Protein Research with Machine Learning-Enabled Bioinformatic Tools. 2024.
  32. Sultana, T., et al., Computational exploration of SLC14A1 genetic variants through structure modeling, protein-ligand docking, and molecular dynamics simulation. Biochemistry and Biophysics Reports, 2024. 38: p. 101703.
  33. Hassan, M.O., et al., In silico analysis of likely pathogenic variants in human GGCX gene. Informatics in Medicine Unlocked, 2020. 19: p. 100337.
  34. Gautam, V., et al., Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system. Molecular Diversity, 2023. 27(2): p. 959-985.
  35. Chua, H.M., et al., Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review. PLoS One, 2024. 19(5): p. e0301396.
  36. Azari, A.A. and A. Arabi, Conjunctivitis: a systematic review. Journal of ophthalmic & vision research, 2020. 15(3): p. 372.
  37. Yates, C.M. and M.J. Sternberg, The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein–protein interactions. Journal of molecular biology, 2013. 425(21): p. 3949-3963.
  38. Garcia, M.M., et al., Toll-like receptor 4: a promising crossroads in the diagnosis and treatment of several pathologies. European Journal of Pharmacology, 2020. 874: p. 172975.

Reference

  1. Gupta, A., et al., Red Eyes—Conjunctivitis, Corneal Ulcers, Dry Eye Disease, and Acute Uveitis, in Ophthalmic Signs in Practice of Medicine. 2024, Springer. p. 493-542.
  2. Gui, S.-Y., et al., Long-term effects of meteorological factors and extreme weather on daily outpatient visits for conjunctivitis from 2013 to 2020: a time-series study in Urumqi, China. Environmental Science and Pollution Research, 2023. 30(20): p. 58041-58057.
  3. Nawaz, S., et al., The Outbreak of Highly Contagious Conjunctivitis (Pink Eye) in Major Cities of Pakistan. The Open Infectious Diseases Journal, 2024. 16(1).
  4. Petrillo, F., et al., Candida Biofilm Eye Infection: Main Aspects and Advance in Novel Agents as Potential Source of Treatment. Antibiotics, 2023. 12(8): p. 1277.
  5. Abebe, T., et al., Bacterial Profile of External Ocular Infections, Its Associated Factors, and Antimicrobial Susceptibility Pattern among Patients Attending Karamara Hospital, Jigjiga, Eastern Ethiopia. International Journal of Microbiology, 2023. 2023(1): p. 8961755.
  6. Rogers, M.S., et al., The classical pink-eyed dilution mutation affects angiogenic responsiveness. PLoS One, 2012. 7(5): p. e35237.
  7. Habib, A., et al., Rising rates of conjunctivitis in Pakistan: epidemic, challenges, solutions, and recommendations. IJS Global Health, 2024. 7(2): p. e0422.
  8. Amjad, S.S., et al., Outbreak of Conjunctivitis in South Asia: A Landscape of Current Situation and Rapid Review of Literature. IJCMCR. 2024; 39 (2). 5.
  9. Said, N., R. Fekry, and H. Elmesallmy, Association between viral Conjunctivitis and Genetic Polymorphisms related to IL-4 and IL-4R in Egyptian Population. Zagazig University Medical Journal, 2022. 28(6.2): p. 333-338.
  10. Kim, H.-J., et al., Toll-like receptor 4 (TLR4): new insight immune and aging. Immunity & Ageing, 2023. 20(1): p. 67.
  11. Manjili, F.A., A. Yousefi-Ahmadipour, and M.K. Arababadi, The roles played by TLR4 in the pathogenesis of multiple sclerosis; a systematic review article. Immunology letters, 2020. 220: p. 63-70.
  12. Wicherska-Paw?owska, K., T. Wróbel, and J. Rybka, Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases. Int J Mol Sci, 2021. 22(24).
  13. Behzadi, P., H.A. García-Perdomo, and T.M. Karpi?ski, Toll?like receptors: general molecular and structural biology. Journal of Immunology Research, 2021. 2021(1): p. 9914854.
  14. Molteni, M., S. Gemma, and C. Rossetti, The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators Inflamm, 2016. 2016: p. 6978936.
  15. Nieto, J.E., et al., Increased expression of tlr4 in circulating cd4+ t cells in patients with allergic conjunctivitis and in vitro attenuation of th2 inflammatory response by alpha-msh. International Journal of Molecular Sciences, 2020. 21(21): p. 7861.
  16. Arbour, N.C., et al., TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet, 2000. 25(2): p. 187-91.
  17. Oscanoa, J., et al., SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update). Nucleic acids research, 2020. 48(W1): p. W185-W192.
  18. Rozario, L.T., T. Sharker, and T.A. Nila, In silico analysis of deleterious SNPs of human MTUS1 gene and their impacts on subsequent protein structure and function. PloS one, 2021. 16(6): p. e0252932.
  19. Venkata Subbiah, H., P. Ramesh Babu, and U. Subbiah, In silico analysis of non-synonymous single nucleotide polymorphisms of human DEFB1 gene. Egyptian Journal of Medical Human Genetics, 2020. 21: p. 1-9.
  20. Thomas, P.D., et al., PANTHER: Making genome?scale phylogenetics accessible to all. Protein Science, 2022. 31(1): p. 8-22.
  21. Dakshitha, S., V. Suresh, and E. Dilipan, Computational exploration of single-nucleotide polymorphisms in the human hRAS gene: Implications and insights. Cureus, 2024. 16(1).
  22. Azmi, M.B., et al., Identification of potential therapeutic intervening targets by in-silico analysis of nsSNPs in preterm birth-related genes. Plos one, 2023. 18(3): p. e0280305.
  23. Hussein, Z.A. and A.A. Al-Kazaz, Bioinformatics evaluation of CRISP2 gene SNPs and their impacts on protein. Iraqi Journal of Agricultural Sciences, 2023. 54(2): p. 369-377.
  24. Mohkam, M., et al., In Silico Evaluation of Nonsynonymous SNPs in Human ADAM33: The Most Common Form of Genetic Association to Asthma Susceptibility. Computational and Mathematical Methods in Medicine, 2022. 2022(1): p. 1089722.
  25. NYIRENDA, F. and C. MEDI, DEVELOPMENT OF WEB-BASED APPLICATION FOR CRIME REPORTING AND HANDLING IN MALAWI POLICE SERVICE. I-Manager's Journal on Computer Science, 2024. 12(1).
  26. Rojas Velazquez, M.N., S. Therkelsen, and A.V. Pandey, Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays. Biomolecules, 2023. 13(12): p. 1728.
  27. Chen, C.-W., et al., iStable 2.0: Predicting protein thermal stability changes by integrating various characteristic modules. Computational and structural biotechnology journal, 2020. 18: p. 622-630.
  28. KUMAR, N., et al., Bioinformatics Tools to Study Homology Modeling. Computational Biology in Drug Discovery and Repurposing, 2024: p. 75.
  29. Muhammed, M.T. and E. Aki-Yalcin, Up-to-Date Developments in Homology Modeling. Applied Computer-Aided Drug Design: Models and Methods, 2023: p. 116.
  30. Datir, S. and P. Ghosh, In silico analysis of the structural diversity and interactions between invertases and invertase inhibitors from potato (Solanum tuberosum L.). 3 Biotech, 2020. 10(4): p. 178.
  31. Guzmán-Vega, F.J., Large Scale Approaches for Protein Research with Machine Learning-Enabled Bioinformatic Tools. 2024.
  32. Sultana, T., et al., Computational exploration of SLC14A1 genetic variants through structure modeling, protein-ligand docking, and molecular dynamics simulation. Biochemistry and Biophysics Reports, 2024. 38: p. 101703.
  33. Hassan, M.O., et al., In silico analysis of likely pathogenic variants in human GGCX gene. Informatics in Medicine Unlocked, 2020. 19: p. 100337.
  34. Gautam, V., et al., Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system. Molecular Diversity, 2023. 27(2): p. 959-985.
  35. Chua, H.M., et al., Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review. PLoS One, 2024. 19(5): p. e0301396.
  36. Azari, A.A. and A. Arabi, Conjunctivitis: a systematic review. Journal of ophthalmic & vision research, 2020. 15(3): p. 372.
  37. Yates, C.M. and M.J. Sternberg, The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein–protein interactions. Journal of molecular biology, 2013. 425(21): p. 3949-3963.
  38. Garcia, M.M., et al., Toll-like receptor 4: a promising crossroads in the diagnosis and treatment of several pathologies. European Journal of Pharmacology, 2020. 874: p. 172975.

Photo
Kainat Ramzan
Corresponding author

Department of Biochemistry, Faculty of Life Science, University of Okara, Punjab, Pakistan

Photo
Hamna Tariq
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Tuba Aslam
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Muhammad Saleem
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Khadija Aaliya
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Aniqa Aamir
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Ali Moazzam Qadri
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Photo
Moeen Zulfiqar
Co-author

Department of Molecular Biology, University of Okara, Punjab, Pakistan.

Tuba Aslam, Humna Tariq*, Muhammad Saleem, Kainat Ramzan*, Khadija Aaliya, Aniqa Aamir, Ali Moazzam Qadri1, Moeen Zulfiqar, Bioinformatic Analysis of Human TLR4 Coding Variations Associated with Ocular Infection: A Structural Prediction and Molecular Docking Studies, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 930-954. https://doi.org/10.5281/zenodo.14325013

More related articles
Fast Dissolving Tablets: An Overview...
Pommala Nagaveni, A. Sreevalli, G. Syam Sundar, ...
A Review on Phytochemical and Formulation Approach...
Anil Kumar Manhar, Deepesh Lall, Ritesh Jain, Abhinay Dehre, Ruch...
A Review on Development of Transdermal Drug Delive...
Manisha Rokade, Pradnya Khandagale, Dr. Vivek Bhyahatti, ...
Related Articles
Apple Serum for Beauty and Health...
Rushikesh Sarkate, Sakshi Kharate, Dr. Swati Deshmukh, ...
Comparative Analysis Of Drug Labeling Requirements In The USA And India: Regul...
Surbhi H. Makvana, Shrikalp Deshpande, Maitreyi Zaveri, ...
Dichrostachys Cinerea: A Comprehensive Review on its Phytochemical & Pharmacolog...
Dr. H. R. Ambujakshi, S. Pooja, H. R. Gowtham Kalyan, N. T. Sachin Gowda, Mohammed Adhil, Shalini Go...
Acids, Bases, and Indicators: Unveiling the Science Behind Colourful Chemistry...
Dr. Swathi Naraparaju, Kiran Babu Nadimpalli, Naga Sai Pranav Koundinya Nadimpalli, ...
Fast Dissolving Tablets: An Overview...
Pommala Nagaveni, A. Sreevalli, G. Syam Sundar, ...
More related articles
Fast Dissolving Tablets: An Overview...
Pommala Nagaveni, A. Sreevalli, G. Syam Sundar, ...
A Review on Phytochemical and Formulation Approaches of Centella Asiatica and Ac...
Anil Kumar Manhar, Deepesh Lall, Ritesh Jain, Abhinay Dehre, Ruchika Chandra, Syed Saif Ullah, ...
A Review on Development of Transdermal Drug Delivery System...
Manisha Rokade, Pradnya Khandagale, Dr. Vivek Bhyahatti, ...
Fast Dissolving Tablets: An Overview...
Pommala Nagaveni, A. Sreevalli, G. Syam Sundar, ...
A Review on Phytochemical and Formulation Approaches of Centella Asiatica and Ac...
Anil Kumar Manhar, Deepesh Lall, Ritesh Jain, Abhinay Dehre, Ruchika Chandra, Syed Saif Ullah, ...
A Review on Development of Transdermal Drug Delivery System...
Manisha Rokade, Pradnya Khandagale, Dr. Vivek Bhyahatti, ...